Developmental Research Program

项目总结/摘要 斯隆纪念医院膀胱癌SPORE发展研究计划（DRP）的目标 凯特琳癌症中心（MSK）是支持创新的转化研究项目，尿路上皮癌， 建立快速筹资机制。发展研究计划基金在膀胱的孢子 癌症，辅以机构资金，将使我们能够支持新的和建立的项目， 这些研究人员对预防、诊断和治疗糖尿病的新思想的产生至关重要， 尿路上皮癌我们将征求具有转化潜力的尿路上皮癌试点项目的建议书， 临床和基础研究人员在更大的MSK社区，包括洛克菲勒大学和威尔 康奈尔医学院。经过DRP董事、内部和外部顾问的严格同行审查， 董事会和病人倡导者，最有前途的新项目，从这个广泛的投资组合发展 研究项目将被选中。将优先考虑补充长期研究的项目 目标的SPORE和推进我们的转化研究目标。DRP还可以征集和资助 解决膀胱MSK SPORE的紧急和特定需求的实验或临床计划 癌症计划或一个独特的研究机会。符合资格的试验计划申请人必须具备 医学博士，医学博士/博士，或博士学位在相关的研究领域，被任命为教师在MSK或 附属机构（威尔康奈尔医学院，洛克菲勒大学），表现出承诺， 从事与尿路上皮癌相关的转化研究，并同意参加所有相关的 在支持期间，与膀胱癌MSK孢子相关的会议和活动。的DRP 致力于遵守和支持MSK的政策和程序，以促进多样性， 加强妇女和代表性不足的少数群体的个人的参与。

PROJECT SUMMARY/ABSTRACT The goal of the Developmental Research Program (DRP) of the SPORE in Bladder Cancer at Memorial Sloan Kettering Cancer Center (MSK) is to support innovative translational research projects in urothelial cancer by establishing mechanisms for rapid funding. Developmental Research Program funds in the SPORE in Bladder Cancer, supplemented by institutional funds, will allow us to support projects by new and established investigators that are critical to the generation of new ideas in the prevention, diagnosis, and treatment of urothelial cancer. We will request proposals for urothelial cancer pilot projects with translational potential from clinical and basic investigators within the larger MSK community, including Rockefeller University and Weill Cornell Medical College. After rigorous peer review by the DRP Directors, Internal and External Advisory Boards, and the Patient Advocate, the most promising new projects from this wide portfolio of developmental research projects will be selected. Preference will be given to projects that complement the long-term research goals of the SPORE and advance our translational research objectives. The DRP may also solicit and fund experimental or clinical initiatives that address an urgent and specific need in the MSK SPORE in Bladder Cancer program or a unique research opportunity. Eligible pilot project applicants to the DRP must have an MD, MD/PhD, or PhD degree in a relevant area of research, be appointed as faculty members at MSK or affiliated institution (Weill Cornell Medical College, Rockefeller University), demonstrate commitment to an academic career in translational research related to urothelial cancer, and agree to participate in all relevant conferences and activities related to the MSK SPORE in Bladder Cancer for the duration of support. The DRP is committed to adhering to and supporting the MSK policies and procedures to promote diversity and strengthen the participation of women and individuals from underrepresented minorities.